Sarah Heerboth
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Biomedical Engineering top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Sibaji SarkarK LapińskaShannon BylerGenevieve HousmanMckenna LongacreMeghan LearyAmber WillbanksKimberly L. Moulton
- Topics
- Epigenetics and DNA Methylation (8 papers)Histone Deacetylase Inhibitors Research (5 papers)Pregnancy and preeclampsia studies (2 papers)
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of Molecular SciencesCancers
- Partner nations
- United States
In The Last Decade
Sarah Heerboth
13 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 2.0k
- Oncology 983
- Cancer Research 710
- Biomedical Engineering 318
- Pulmonary and Respiratory Medicine 283
Countries citing papers authored by Sarah Heerboth
This map shows the geographic impact of Sarah Heerboth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Heerboth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Heerboth more than expected).
Fields of papers citing papers by Sarah Heerboth
This network shows the impact of papers produced by Sarah Heerboth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Heerboth. The network helps show where Sarah Heerboth may publish in the future.
Co-authorship network of co-authors of Sarah Heerboth
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Heerboth. A scholar is included among the top collaborators of Sarah Heerboth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Heerboth. Sarah Heerboth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 16 | |
| 5 | 125 | |
| 6 | 21 | |
| 7 | 42 | |
| 8 | 49 | |
| 9 | EMT and tumor metastasisbreakdown → | 594 |
| 10 | Drug Resistance in Cancer: An Overviewbreakdown → | 1906 |
| 11 | Genetic and epigenetic aspects of breast cancer progression and therapy. | 160 |
| 12 | 220 | |
| 13 | 51 | |
| 14 | Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor. | 34 |
About Sarah Heerboth
Sarah Heerboth is a scholar working on Obstetrics and Gynecology, Pharmaceutical Science and Molecular Biology, having authored 14 papers that have together received 3.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (5 papers) and Pregnancy and preeclampsia studies (2 papers). The work is most often cited by research in Cancer Research (710 citations), Oncology (983 citations) and Molecular Biology (2.0k citations). Sarah Heerboth has collaborated with scholars based in United States. Frequent co-authors include Sibaji Sarkar, K Lapińska, Shannon Byler, Genevieve Housman, Mckenna Longacre, Meghan Leary, Amber Willbanks, Kimberly L. Moulton, Kathryn Haskins and Troy D. Moon. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.